Researcher
Tessa Kerre
- Keywords:Hematology, Stem cell transplantation, Cell therapy, Immunology, primary immunedeficiencies, immunotherapy, Bibliotherapy
- Disciplines:Hematology, Immunology not elsewhere classified
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → 30 Sep 2021 - Department of Internal medicine (Department)
Member
From1 Oct 2010 → 30 Sep 2018 - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Oct 1997 → 30 Sep 2018
Projects
1 - 5 of 5
- Chimeric antigen receptor unconventional T cell therapy (CAR-uT) for the treatment of solid tumorsFrom1 Nov 2023 → TodayFunding: FWO junior postdoctoral fellowship
- Optimisation of CD70-targeted adoptive cell therapyFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Digital innovation for man and societyFrom1 Jan 2020 → TodayFunding: BOF - research organisations
- CancerInMotionFrom15 Jul 2019 → 15 May 2021Funding: IOF - technology concept exploration
- Treatment of minimal residual disease positive acute myeloid leukemia patientsFrom1 Jan 2015 → 31 Dec 2018Funding: Nonprofit institution or equivalents
Publications
11 - 20 of 70
- Upper and/or lower respiratory tract infection caused by human metapneumovirus after allogeneic stem cell transplantation(2022)Volume: 57
Authors: J. L. Pinana, G. Tridelo, A. Xhaard, L. Wendel, J. Montoro, L. Vazquez, I. Heras, P. Ljungman, M. Mikulska, U. Salmen-Niemi, et al.
Pages: 60 - 61 - Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50(2022)
Authors: Manfred Fliegauf, Matias Kinnunen, Sara Posadas-Cantera, Nadezhda Camacho-Ordonez, Hassan Abolhassani, Laia Alsina, Faranaz Atschekzei, Delfien Bogaert, Siobhan O. Burns, Joseph A. Church, et al.
- Biological correlative analyses and updated clinical data of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy : CARTITUDE-2, cohort B(2022)Volume: 40
Authors: Niels W. C. J. van de Donk, Mounzer E. Agha, Adam D. Cohen, Yael C. Cohen, Sebastien Anguille, Tessa Kerre, Wilfried Roeloffzen, Jordan Mark Schecter, Kevin C. De Braganca, Helen Varsos, et al.
Number of pages: 1 - Phase 2 CARTITUDE-2 study (cohort B) : updated clinical data and biological correlative analyses of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy(2022)Volume: 22
Authors: Mounzer Agha, Niels W. C. J. van de Donk, Adam D. Cohen, Yael C. Cohen, Sebastien Anguille, Tessa Kerre, Wilfried Roeloffzen, Jordan M. Schecter, Kevin C. De Braganca, Helen Varsos, et al.
Pages: S408 - S409 - Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT) : a prospective study from the Belgian Hematology Society (BHS)(2022)
Authors: Xavier Poire, Carlos Graux, Aurelie Ory, Julie Herman, Frederic Baron, Helene Schoemans, Philippe Lewalle, Ann De Becker, Dries Deeren, Zwi Berneman, et al.
Pages: 116 - 118 - Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy(2022)
Authors: Elena Catanzaro, Eleonora Turrini, Tessa Kerre, Simon Sioen, Ans Baeyens, Alessandra Guerrini, Mohamed Lamin Abdi Bellau, Gianni Sacchetti, Guglielmo Paganetto, Dmitri Krysko, et al.
- CARTITUDE-2 cohort B : efficacy and safety of ciltacabtagene autoleucel, a chimeric antigen receptor T-cell therapy directed against B-cell maturation antigen, in patients with multiple myeloma and early relapse after initial treatment(2022)Volume: 197
Authors: Niels W. C. J. Van de Donk, Michel Delforge, Mounzer Agha, Adam D. Cohen, Yael C. Cohen, Jens Hillengass, Sebastien Anguille, Tessa Kerre, Wilfried Roeloffzen, Jordan M. Schecter, et al.
Pages: 118 - 119 - Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer : a study of the Chronic Malignancies Working Party of the EBMT(2022)
Authors: Mitja Nabergoj, Katya Mauff, Dietrich Beelen, Arnold Ganser, Nicolaus Kröger, Friedrich Stölzel, Jürgen Finke, Jakob Passweg, Jan Cornelissen, Natalie Schub, et al.
Pages: 1072 - 1078 - Ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy : CARTITUDE-2 cohort B 18-month follow-up(2022)Volume: 140
Authors: Niels W. C. J. Van de Donk, Mounzer Agha, Adam D. Cohen, Yael C. Cohen, Sebastien Anguille, Tessa Kerre, Wilfried W. H. Roeloffzen, Jordan M. Schecter, Kevin C. De Braganca, Carolyn C. Jackson, et al.
Pages: 7536 - 7537 - Fecal microbiota transplantation in the treatment of acute gastrointestinal graft-versus-host disease : a retrospective survey of the transplant complications working party of EBMT(2022)Volume: 57
Authors: J. Bilinski, G. W. Basak, K. Halaburda, D. Wu, O. Goloshchapov, S. Maury, A. Tanase, G. Van Gorkom, Anke Delie, Tessa Kerre, et al.
Pages: 186 - 187